Beacon Pointe Advisors, LLC Edwards Lifesciences Corp Transaction History

Beacon Pointe Advisors, LLC

$8.55 Billion
Q3 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 33,788 shares of EW stock, worth $2.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

33,788

Previous 37,646 10.25%

Holding current value

$2.5 Million

Previous $3.48 Million 35.89%

% of portfolio

0.03%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $230,322 - $361,803	-3,858 Reduced 10.25%	33,788 $2.23 Million
Q2 2024 Aug 12, 2024	SELL	$84.3 - $94.31 $109,758 - $122,791	-1,302 Reduced 3.34%	37,646 $3.48 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $78,778 - $103,778	-1,086 Reduced 2.71%	38,948 $3.72 Million
Q4 2023 Feb 08, 2024	SELL	$61.71 - $77.76 $275,720 - $347,431	-4,468 Reduced 10.04%	40,034 $3.05 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $318,410 - $429,174	4,596 Added 11.52%	44,502 $3.08 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $221,272 - $256,388	2,718 Added 7.31%	39,906 $3.76 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $19,159 - $21,803	-258 Reduced 0.69%	37,188 $3.08 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $61,879 - $79,220	-906 Reduced 2.36%	37,446 $2.79 Million
Q3 2022 Nov 09, 2022	SELL	$82.37 - $107.29 $773,371 - $1.01 Million	-9,389 Reduced 19.67%	38,352 $3.16 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $2.38 Million - $3.53 Million	-27,514 Reduced 36.56%	47,741 $4.54 Million
Q1 2022 May 17, 2022	BUY	$101.96 - $128.34 $4.45 Million - $5.6 Million	43,655 Added 138.15%	75,255 $8.86 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $4.45 Million - $5.46 Million	-41,804 Reduced 56.95%	31,600 $4.09 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $4.98 Million - $5.94 Million	48,392 Added 193.48%	73,404 $8.31 Million
Q2 2021 Aug 17, 2021	BUY	$83.84 - $104.76 $74,952 - $93,655	894 Added 3.71%	25,012 $2.59 Million
Q1 2021 May 18, 2021	SELL	$78.68 - $90.67 $206,062 - $237,464	-2,619 Reduced 9.8%	24,118 $2.02 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $196,287 - $249,787	2,738 Added 11.41%	26,737 $2.44 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $537 - $699	8 Added 0.03%	23,999 $1.92 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $918,050 - $1.23 Million	15,955 Added 198.54%	23,991 $1.66 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $285,739 - $441,612	5,452 Added 210.99%	8,036 $1.52 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $12,977 - $14,858	181 Added 7.53%	2,584 $602,000
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $22,034 - $27,003	-358 Reduced 12.97%	2,403 $528,000
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $20,958 - $24,218	376 Added 15.77%	2,761 $512,000
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $16,474 - $22,033	344 Added 16.85%	2,385 $458,000
Q4 2018 Feb 01, 2019	BUY	$46.41 - $56.94 $94,722 - $116,214	2,041 New	2,041 $312,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Edwards Lifesciences Corp Transaction History